ACIP recommendation for COVID booster for children

Translate to Spanish or other 102 languages!

“We applaud the Advisory Committee on Immunization Practices (ACIP) for their thoughtful deliberations and recommendation supporting that children ages 5-11 should receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine, at least five months after completion of the primary series. Image or illustration purposes
“We applaud the Advisory Committee on Immunization Practices (ACIP) for their thoughtful deliberations and recommendation supporting that children ages 5-11 should receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine, at least five months after completion of the primary series. Image or illustration purposes

Mega Doctor News

- Advertisement -
Gerald E. Harmon, MD
President, American Medical Association
Courtesy Image

The following statement is attributable to:
Gerald E. Harmon, MD
President, American Medical Association

“We applaud the Advisory Committee on Immunization Practices (ACIP) for their thoughtful deliberations and recommendation supporting that children ages 5-11 should receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine, at least five months after completion of the primary series. Based on what we know from other age groups, vaccine effectiveness against SARS-CoV-2 infection declines over time and vaccine booster doses have been shown to increase protection against all outcomes. With the highly transmissible Omicron variant continuing to evolve, strengthened neutralizing antibodies from the booster dose provides an additional layer of protection.

“The scientific evidence is clear that the vaccines against COVID-19 are safe and remain effective in preventing hospitalization and severe disease. It is concerning that only one in three children between the ages of 5 and 11 in the United States have received two doses of the vaccine, in part because parents believe them to be at lower risk for severe disease than adults. But the Omicron variant brought about change that should alter that calculus. According to the Centers for Disease Control and Prevention (CDC), the highly transmissible variant not only sent more children to the hospital and ICU than previous waves, but children who were unvaccinated were twice as likely to be hospitalized as those were vaccinated.

- Advertisement -

“Against this backdrop, we continue to strongly urge those who are eligible to stay up to date on their COVID-19 vaccines, including booster doses, to protect themselves and their loved ones from severe complications, hospitalization, and death. We look forward to the deliberations of the FDA’s Vaccines and Related Biological Products Advisory Committee and the ACIP on COVID-19 vaccine for kids under the age of 5, as many families are anxiously awaiting a safe and effective vaccine for this population.”

“Anyone with questions about the vaccines should speak with their physician and review trusted resources, including getvaccineanswers.org.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -